Human immunodeficiency virus (HIV) infection causes
severe alterations in the adaptive immune system, including the depletion of CD4 T cells and the expansion of HIVspecific and nonspecific CD8 T cells [1] . These alterations imply an inversion of the CD4/CD8 ratio that persists even after long-term successful antiretroviral treatment, particularly if treatment initiation is delayed [2] [3] [4] . Recently, the persistence of an inverted CD4/CD8 ratio has been extensively associated with increased morbimortality in HIV-infected subjects [5] [6] [7] [8] [9] .
The CD4/CD8 ratio has been associated with markers of T cell activation and senescence [10] [11] [12] . More recently, cytomegalovirus (CMV) coinfection was found to directly drive the CD8 T cell expansion, thereby supporting the persistence of a low peripheral CD4/CD8 ratio in successfully treated HIVinfected subjects [13] [14] [15] . Both a low CD4/CD8 T cell ratio and CMV seropositivity were characteristic of the immune risk profile (IRP), which has been associated with the morbimortality of HIV-uninfected elderly [16, 17] .
The thymus is responsible for the production of both CD4 and CD8 naive T cells and remains functional in the human adult [18] . Moreover, the thymus is involved in the immune restoration of HIV-infected subjects during antiretroviral treatment [19] . On the other hand, age-associated thymic involution could impact the immunosenescent profile of elderly subjects. Consistently, we recently described the thymic function failure as an independent predictor of all-cause mortality in uninfected elderly humans [20] . However, to the best of our knowledge, the impact of the thymic function on the peripheral CD4/CD8 ratio of HIV-uninfected and HIV-infected subjects has not been explored to date.
We explored the impact of thymic function on the CD4/CD8 ratio of HIV-infected subjects before and during antiretroviral treatment.
DESIGN AND METHODOLOGY

Study Design
We analyzed data from a previously reported cohort that was created from 1998 to 2002 [19] . Briefly, this cohort included consecutive, antiretroviral-naive and asymptomatic HIV-1-infected subjects starting antiretroviral treatment (defined by 2 nucleoside reverse transcriptase inhibitors plus a protease or a non-nucleoside reverse transcriptase inhibitor or both).
Patients were recruited for a thoracic computed tomography (CT) scan for the measurement of the thymic volume at baseline and at weeks 12, 24, and 48 of antiretroviral treatment for the purposes previously described [19] . At each visit defined above and after 96 weeks of antiretroviral treatment, CD4 and CD8 T cell counts and HIV-1 RNA levels were routinely determined in fresh blood samples. Written informed consent had been obtained for every patient included in the study.
Computed Tomography (CT) Scans
Mediastinal CT scans had been performed with a modified method as described [21] . Briefly, CT scans were obtained on a 3000 GE Sytec scanner, using 5-mm thick contiguous sections at 5-mm intervals. Measurements were always performed by the same radiologist, who worked with coded samples. For the determination of the thymic volume, the first and last slices containing thymic tissue were identified. Then, thymic tissue in all the slices between the first and the last was carefully delimited to exclude mediastinal fat infiltration, based on the different density observed (higher density for soft tissues and lower density for surrounding fat). The software (CT Sytec software, 2.02 version) then integrated all the defined thymic areas across the slices (being the first and last slice volumes automatically halved to account for partial volume averaging) and gave the calculated thymic volume in cubic centimeters.
Laboratory Measurements
Peripheral blood samples had been collected and cryopreserved in most subjects at baseline and at follow-up time points (12, 24 and 48 weeks). In cryopreserved peripheral blood mononuclear cell samples we determined the delta T cell Receptor Excision Circles (delta-TRECs) level, by a real-time PCR (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany) using an external standard curve made with DNA from a unique pediatric thymic sample for the entire study. Briefly, both the characteristic signal-joint sequences harbored by delta-TRECs and the genomic β-globin gene sequences (to normalize by DNA content) were quantified in duplicate PCR reactions. All samples available were PCR-positives for delta-TRECs, with a distribution between 100 and 11 000 delta-TRECs/ 10 6 PBMCs (Peripheral Blood Mononuclear Cells).
Details of the PCR conditions and the primers and probes sequences can be found elsewhere [19] . Additionally, CD4 and CD8 naive T cell subsets had been determined by flow-cytometry using the following phenotypes: CD4 + CD45RA + CD45RO -and CD8 + CD45RA + CD11a low [22] , whereas memory T cell subsets had been determined by excluding naives from the total corresponding pool.
Statistical Methods
Continuous variables are expressed as median values and interquartile range (IQR). Categorical variables are expressed as numbers and percentages. Correlations were assessed using the Spearman rank test. Longitudinal comparisons were assessed using the Friedman test for multiple comparisons and the Wilcoxon rank-sum test for paired comparisons. Patient demographic and clinical characteristics together with thymic volume were compared between those subjects with normalized or not the CD4/CD8 ratio 96 weeks after successful treatment using the Mann-Whitney U and Chi-square tests for continuous and categorical variables, respectively. We used a CD4/CD8 ratio ≥1.2 as the definition for "normalization"; this definition was also used in recent publications [2, 23] . A sensitivity analysis was conducted to examine the effects of defining normalization of the CD4/CD8 ratio as ≥1. A multivariate logistic regression was fitted to evaluate the adjusted effect of these variables on the normalization of the CD4/CD8 ratio (variables presenting P-values < .2 in the univariate logistic regression were introduced into the multivariate analysis).
Odds ratios with 95% confidence intervals (CIs) are shown.
A P-value < .05 was considered statistically significant. The statistical analysis was performed using the Statistical Package for the Social Sciences software (SPSS 21.0, USA). Graphs were generated using Prism version 5.0 (GraphPad Software, USA).
RESULTS
Baseline Characteristics of the Study Subjects
Baseline characteristics of the subjects can be found in Table 1 . This cohort showed relatively low baseline CD4 T cell counts and CD4/CD8 ratio and included a high proportion of subjects with injection drug use, previous C event and HCV coinfection. For a follow-up analysis we retained only subjects who reached undetectability during the study period (up to 48 weeks). This follow-up subgroup of the study (n = 33) included a lower proportion of subjects with these characteristics, probably due to the lower adherence and/or the higher risk of virological failure related to these subjects.
Baseline Thymic Function Was Associated With the CD4/CD8 Ratio and This Association Was Highly Dependent on the CD4 T Cell Level
Data of thymic volume, as a representative measurement of thymic function, and of delta-TRECs levels (representing the result of a complex equilibrium between thymic output and peripheral proliferation and cell death) are shown in Table 1 . Both parameters were positively associated with the CD4/ CD8 ratio ( Figure 1, a-b) . Interestingly, we observed that these associations were highly dependent on the level of CD4 T cells when categorized by its median value. Thus, the CD4/CD8 ratio correlated with the thymic volume only in the population with higher level of CD4 T cells and correlated with delta-TRECs only in the population with lower level of CD4 T cells (Figure 1 , c-f). Intriguingly, despite the correlation between thymic volume and the CD4 T cell counts was modest (ρ = 0.298, P = Figure 1 . Correlations between the thymic volume (a) and delta-TREC levels (b) with the CD4/CD8 ratio in all antiretroviral-naive subjects. After categorizing by the median CD4 T cell count (289 cells/mL), these correlations are also shown in subjects with lower CD4 T cell count (c, d) and in subjects with higher CD4 T cell count (e, f). A logarithmic scale is shown of the corresponding axis for the delta-TRECs. The Spearman test was used for correlation testing. Abbreviations: PBMC, peripheral blood mononuclear cells; TREC, T cell receptor excision circles.
.03) and the correlation with CD8 T cell counts was absent (ρ = −0.057, P = .7), thymic volume strongly correlated with the ratio of both subsets (ρ = 0.413, P = .002).
Baseline Thymic Volume Was Associated With the Evolution of The CD4/ CD8 Ratio After Treatment
In the subgroup of subjects with a full virological response to treatment (follow-up subgroup), the CD4/CD8 ratio improved throughout the follow-up ( Figure 2a ). As can be observed, this occurred independently on the baseline thymic volume, but range values were lower in subjects with lower baseline thymic volume. Positive correlations between baseline thymic volume and post-treatment CD4/CD8 ratios at the different timepoints of the follow-up were observed (Supplementary Table  1 ). Next, we explored the effect of the baseline thymic volume on the evolution of the individual CD4 and CD8 T cell counts, categorized by its median value. Thus, subjects with lower baseline thymic volume improved their CD4 T cell counts but did not change their CD8 T cell counts. However, a higher baseline thymic volume was associated with both an increase in CD4 T cells and a decreasing trend in CD8 T cells ( Figure  2a ). The effect of the thymic volume on naïve and memory CD4 and CD8 T cell subsets is shown in Supplementary  Figure 1 .
Baseline Thymic Volume Was Independently Associated With the CD4/ CD8 Ratio Normalization After 96 Weeks of Successful-Treatment
In the follow-up subgroup, less than 10% of the subjects reached a CD4/CD8 ratio ≥1.2 after 48 weeks of suppressive treatment, although 30% (10/33) of the subjects reached this value 1 year later. Thus, we analyzed the role of baseline thymic function on the normalization of the CD4/CD8 ratio after 96 weeks of treatment. We categorized this follow-up subgroup by its median value for baseline thymic volume. Only 1/16 (6%) subjects in the "low baseline thymic volume" group normalized the CD4/CD8 ratio compared to 9/17 (53%) in the "high baseline thymic volume" group (χ2 test; P = .004). In a multivariate analysis, the baseline thymic volume was independently associated with normalization of the CD4/CD8 ratio after adjusting by age and baseline CD4 T cell counts and viral load (OR, 1.95 [95% CI, 1.07-3.55]; P = .03) ( Table 2) . We found similar results in the sensitivity analysis using a cut-off of 1 for normalization (data not shown).
Relationships Between Thymic Function-Related Markers and the CD4 and CD8 Naive and Memory T Cell Compartments
We also explored the associations between the baseline thymic function-related markers and the naive and memory CD4 and CD8 T cell compartments (Supplementary Table 2 ). In the case of naive subsets, both the thymic volume and the delta-TREC levels were associated with the individual pools. However, only the thymic volume was associated with the naive CD4/naive CD8 T cell ratio. Unexpectedly, the thymic volume strongly correlated with the memory CD4/memory CD8 T cell ratio, despite the absence of a direct association with the individual memory CD8 subset and a trend for association with the individual memory CD4 subset.
DISCUSSION
We explored for the first time the impact of thymic function on the CD4/CD8 ratio of HIV-infected subjects and found associations with the baseline thymic volume and the CD4/CD8 ratio before and after treatment in antiretroviral-naive subjects. Outstandingly, the baseline thymic volume was associated with the CD4/CD8 ratio normalization 96 weeks after successful treatment. Recently, the persistence of an inverted CD4/CD8 ratio has been extensively associated with the increased morbimortality in HIV-infected subjects [5] [6] [7] [8] [9] . Our observation of an association between the baseline thymic function and the normalization of the CD4/CD8 ratio indicate the relevance of the remaining thymic function just before starting treatment on the clinical progression of HIV-infected subjects. In accordance, previous results from our group showed that the baseline thymic volume predicted CD4 recovery in different settings [24] [25] [26] . Importantly, early vs. delayed treatment has proven its beneficial effect on the normalization of the CD4/CD8 ratio [2] [3] [4] . Therefore, it will be interesting to explore whether this early vs. delayed treatment effect could be explained by a more preserved thymic function.
Interestingly, we have observed that the effect of baseline thymic function on post-treatment CD4/CD8 ratios was only present if undetectable viral loads were achieved and maintained. In fact, this correlation was not found in the entire study group (data not shown). It is possible that new periods of detectable viremia could further damage thymic tissue, thereby setting a new "baseline" thymic function value. In fact, it has been recently described a progressive damage in thymic function during exposure to HIV prior to treatment initiation [27] .
The thymic volume represents the ability of the thymus to export recent thymic emigrants (RTEs), whereas the delta-TRECs represent the result of a complex equilibrium between the thymic output and peripheral proliferation and cell death [21, 22, 28] . In the context of deeper CD4-lymphocytopenia, higher peripheral proliferation of T cells would be expected. In fact, enhanced peripheral proliferation of CD4 and CD8 naive T cells has been documented in humans with lower level of CD4 T cells and/or lower thymic function, as the situation in HIVuninfected thymectomized subjects [29] . Consistently, we only observed a correlation between delta-TRECs and the CD4/CD8 ratio in all studied subjects (who have relatively low median CD4 T cell counts) and also when the analysis was restricted to subjects with CD4 T cells below the median value. In contrast, preserved CD4 T cell counts would rely on higher thymic export instead of peripheral proliferation. In accordance, we observed a strong correlation between the thymic volume and CD4/CD8 ratio when analyzing subjects with higher CD4 T cell counts.
At the moment, the effects of intrinsic host factors on the CD4/ CD8 ratio as a surrogate marker for clinical outcome are being consigned to oblivion, because exogenous factors are considered the main inducers of CD8 T cell persistent elevation [30] . In fact, recent reports evidence that CMV coinfection directly drive the CD8 T cell expansion that supports the persistence of a low peripheral CD4/ CD8 ratio in successfully treated HIV-infected subjects [13] [14] [15] . Moreover, it is assumed that the CD8 T cell pool is not as significantly influenced by homeostatic forces as the CD4 pool [31] . However, our results indicate an impact of thymic function on the level of both, CD4 T cells and CD8 T cells and on their peripheral proportion. In fact, the correlation between thymic volume and CD4/CD8 ratio was stronger than the correlation between thymic volume and the individual CD4 T cell subset. Moreover, a higher thymic volume was associated with a higher increase in CD4 T cells counts and a decreasing trend in CD8 T cell counts during the follow-up. This finding suggests that the expansion of CD8 T cells could also rely on the thymic output and deserves future investigation.
Because the thymus exports RTEs that directly fill the peripheral pool of naive T cells, it is not surprising that the thymic volume correlated with the ratio of circulating CD4 and CD8 naive subsets. However, the thymic volume also showed a tight association with the ratio of both memory subsets, and with the corresponding ratios of CD4 and CD8 naive/memory T cells, suggesting a thymic contribution not only to the circulating naive subsets but also to their peripheral maturation and differentiation into memory T cells. Interestingly, naive T cells can rapidly convert to memory-like phenotypes in peripheral tissues during homeostatic pressure (i.e., in the context of low T cell counts) [32] . This hypothesis needs to be tested but is supported by the recent work of Serrano-Villar et al [8] that describes a prominent immunosenescent profile of CD8 T cell pool in the context of low CD4/CD8 ratios: less proportion of naive but higher of terminally differentiated memory CD8, harboring a low replicative capacity and an activated and exhausted phenotype. Our analysis is limited by the relatively low number of subjects, although the longitudinal approach gives added value to this work. Moreover, we based our naive/memory quantification on old-style phenotyping, though results with these phenotypes seem consistent. Moreover, we used the thymic volume as a marker of thymic function/output, also considering its negative correlation with age and its positive correlation with naive T cells and with delta-TREC levels [19] . Other direct measures on the thymic tissue, like the amount of CD4+CD8+ double positive cells [33] or the thymic score [34] have been also used as surrogate markers of thymic function. However, they are also difficult to assess and future approaches should make use of the determination of the delta/beta TREC ratio, which is probably the gold standard for the peripheral measure of thymic function [35, 36] , which has been already used in the elderly and the HIV scenarios [20, 27, 37] . This approach would also avoid exposure to CT scans.
Despite these limitations, the data presented herein are conceptually novel and relevant and show that the pre-treatment thymus contributes to the peripheral CD4/CD8 ratio of chronic HIV-infected subjects, which is associated with their morbimortality. Our data suggest that thymic function should be seriously considered as a potential therapeutic target in this scenario. Furthermore, because thymic function shows a large constitutive variability both in adult healthy humans [38] and in the HIV scenario [37] , our data also open new questions concerning the potential relevance that the thymic function at the moment of HIV infection could have on future clinical progression.
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